Susanne Schnittger

35.2k total citations · 2 hit papers
435 papers, 17.5k citations indexed

About

Susanne Schnittger is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Susanne Schnittger has authored 435 papers receiving a total of 17.5k indexed citations (citations by other indexed papers that have themselves been cited), including 343 papers in Hematology, 188 papers in Genetics and 159 papers in Molecular Biology. Recurrent topics in Susanne Schnittger's work include Acute Myeloid Leukemia Research (300 papers), Chronic Myeloid Leukemia Treatments (122 papers) and Chronic Lymphocytic Leukemia Research (96 papers). Susanne Schnittger is often cited by papers focused on Acute Myeloid Leukemia Research (300 papers), Chronic Myeloid Leukemia Treatments (122 papers) and Chronic Lymphocytic Leukemia Research (96 papers). Susanne Schnittger collaborates with scholars based in Germany, United States and United Kingdom. Susanne Schnittger's co-authors include Torsten Haferlach, Wolfgang Kern, Claudia Schoch, Claudia Haferlach, Wolfgang Hiddemann, Ulrike Bacher, Alexander Kohlmann, Frank Dicker, Tamara Alpermann and Martin Dugas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Genetics.

In The Last Decade

Susanne Schnittger

419 papers receiving 17.2k citations

Hit Papers

Analysis of FLT3 length m... 2001 2026 2009 2017 2002 2001 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease
    2002 746 citations Susanne Schnittger, Claudia Schoch et al. Blood profile →
  2. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia
    2001 681 citations Pu Zhang, Hanna S. Radomska et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susanne Schnittger Germany 71 13.1k 7.7k 6.2k 3.8k 2.1k 435 17.5k
D. Gary Gilliland United States 62 8.1k 0.6× 8.4k 1.1× 4.2k 0.7× 2.3k 0.6× 1.7k 0.8× 126 16.2k
Gordon W. Dewald United States 57 7.7k 0.6× 4.4k 0.6× 5.2k 0.8× 2.2k 0.6× 602 0.3× 212 13.1k
Nicholas C.P. Cross United Kingdom 75 11.5k 0.9× 7.1k 0.9× 8.5k 1.4× 1.7k 0.5× 1.3k 0.6× 395 19.9k
Rhett P. Ketterling United States 59 9.1k 0.7× 6.6k 0.9× 7.0k 1.1× 1.0k 0.3× 720 0.3× 402 14.4k
Cristina Mecucci Italy 47 5.7k 0.4× 4.1k 0.5× 2.5k 0.4× 1.8k 0.5× 905 0.4× 265 9.5k
Ghulam J. Mufti United Kingdom 55 7.7k 0.6× 4.0k 0.5× 2.9k 0.5× 1.3k 0.3× 731 0.4× 268 11.2k
Marilyn L. Slovak United States 46 6.9k 0.5× 4.4k 0.6× 2.3k 0.4× 2.8k 0.7× 653 0.3× 152 11.7k
Bertil Johansson Sweden 55 4.5k 0.3× 4.5k 0.6× 1.7k 0.3× 2.9k 0.8× 2.1k 1.0× 233 10.8k
Letizia Foroni United Kingdom 46 6.1k 0.5× 2.3k 0.3× 4.0k 0.6× 3.2k 0.8× 449 0.2× 186 9.9k
H. R. Gralnick United States 21 7.9k 0.6× 2.8k 0.4× 2.7k 0.4× 2.8k 0.7× 517 0.3× 34 10.6k

Countries citing papers authored by Susanne Schnittger

Since Specialization
Citations

This map shows the geographic impact of Susanne Schnittger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susanne Schnittger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susanne Schnittger more than expected).

Fields of papers citing papers by Susanne Schnittger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susanne Schnittger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susanne Schnittger. The network helps show where Susanne Schnittger may publish in the future.

Co-authorship network of co-authors of Susanne Schnittger

This figure shows the co-authorship network connecting the top 25 collaborators of Susanne Schnittger. A scholar is included among the top collaborators of Susanne Schnittger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susanne Schnittger. Susanne Schnittger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lang, Fabian, Lydia Wunderle, Eberhard Schleyer, et al.. (2020). A phase I study of a dual PI3-kinase/mTOR inhibitor BEZ235 in adult patients with relapsed or refractory acute leukemia. BMC Pharmacology and Toxicology. 21(1). 70–70. 28 indexed citations
2.
Kern, Wolfgang, Ulrike Bacher, Claudia Haferlach, et al.. (2016). Multiparameter Flow Cytometry Provides Independent Prognostic Information in Patients with Suspected Myelodysplastic Syndromes: A Study on 804 Patients. Cytometry Part B Clinical Cytometry.
3.
Kern, Wolfgang, Ulrike Bacher, Claudia Haferlach, et al.. (2015). Multiparameter flow cytometry provides independent prognostic information in patients with suspected myelodysplastic syndromes: A study on 804 patients. Cytometry Part B Clinical Cytometry. 88(3). 154–164. 15 indexed citations
4.
Bacher, Ulrike, Wolfgang Kern, Tamara Alpermann, et al.. (2012). Prognoses of MDS subtypes RARS, RCMD and RCMD-RS are comparable but cytogenetics separates a subgroup with inferior clinical course. Leukemia Research. 36(7). 826–831. 8 indexed citations
5.
Meggendorfer, Manja, Andreas Roller, Torsten Haferlach, et al.. (2012). SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML). Blood. 120(15). 3080–3088. 219 indexed citations
6.
Schnittger, Susanne, Ulrike Bacher, Tamara Alpermann, et al.. (2012). Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 cases. Haematologica. 97(12). 1890–1894. 21 indexed citations
7.
8.
Bacher, Ulrike, Torsten Haferlach, Tamara Alpermann, et al.. (2011). Subclones with the t(9;22)/BCR‐ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations. British Journal of Haematology. 152(6). 713–720. 41 indexed citations
9.
Bacher, Ulrike, Torsten Haferlach, Susanne Schnittger, et al.. (2010). Detection of a t(4;14)(p16;q32) in two cases of lymphoma showing both the immunophenotype of chronic lymphocytic leukemia. Cancer Genetics and Cytogenetics. 200(2). 170–174. 6 indexed citations
10.
Bacher, Ulrike, Torsten Haferlach, Tamara Alpermann, et al.. (2010). Several lymphoma‐specific genetic events in parallel can be found in mature B‐cell neoplasms. Genes Chromosomes and Cancer. 50(1). 43–50. 23 indexed citations
11.
Bojko, Peter, Wolfgang Abenhardt, Susanne Schnittger, & Torsten Haferlach. (2009). Mutations in the <i>JAK2</i> and <i>MPL</i> Genes and their Correlation to Clinical Parameters in Patients with Chronic Myeloproliferative Disease. Oncology Research and Treatment. 32(4). 191–195. 3 indexed citations
12.
Akagi, Tadayuki, Seishi Ogawa, Martin Dugas, et al.. (2009). Frequent genomic abnormalities in acute myeloid leukemia/myelodysplastic syndrome with normal karyotype. Haematologica. 94(2). 213–223. 59 indexed citations
13.
Bacher, Ulrike, Claudia Haferlach, Susanne Schnittger, et al.. (2009). Interactive diagnostics in the indication to allogeneic SCT in AML. Bone Marrow Transplantation. 43(10). 745–756. 12 indexed citations
14.
Büchner, Thomas, Wolfgang E. Berdel, Claudia Haferlach, et al.. (2008). Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group. Journal of Clinical Oncology. 27(1). 61–69. 232 indexed citations
15.
Radomska, Hanna S., Daniela S. Daniela Sanchez Bassères, Rui Zheng, et al.. (2006). Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations. The Journal of Experimental Medicine. 203(2). 371–381. 161 indexed citations
16.
Weisser, Maja, Michael Schleuning, Georg Ledderose, et al.. (2004). Reduced-intensity conditioning using TBI (8 Gy), fludarabine, cyclophosphamide and ATG in elderly CML patients provides excellent results especially when performed in the early course of the disease. Bone Marrow Transplantation. 34(12). 1083–1088. 32 indexed citations
17.
Bassères, Daniela S. Daniela Sanchez, Hanna S. Radomska, David Sternberg, et al.. (2003). Differentiation block in FLT3 mutant AML by inactivation of C/EBPalpha function by phosphorylation. Blood. 102(11). 17216. 1 indexed citations
18.
Kern, Wolfgang, Claudia Schoch, Alexander Kohlmann, et al.. (2003). Multi-genetic basis for prognostication in acute myeloid leukemia with aberrant and prognostically intermediate karyotypes as determined by gene expression profiling. Blood. 102(11). 190. 1 indexed citations
19.
Griesinger, Frank, Michael Falk, Anja Renziehausen, et al.. (1999). Leukaemia‐associated immunophenotypes (LAIP) are observed in 90% of adult and childhood acute lymphoblastic leukaemia: detection in remission marrow predicts outcome. British Journal of Haematology. 105(1). 241–255. 49 indexed citations
20.
Griesinger, Frank, Michael Falk, Anja Renziehausen, et al.. (1999). Leukaemia-associated immunophenotypes (LAIP) are observed in 90% of adult and childhood acute lymphoblastic leukaemia: detection in remission marrow predicts outcome. British Journal of Haematology. 105(1). 241–255.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Gary Gilliland Breakdown of academic impact, for papers by Gordon W. Dewald Breakdown of academic impact, for papers by Nicholas C.P. Cross Breakdown of academic impact, for papers by Rhett P. Ketterling Breakdown of academic impact, for papers by Cristina Mecucci Breakdown of academic impact, for papers by Ghulam J. Mufti Breakdown of academic impact, for papers by Marilyn L. Slovak Breakdown of academic impact, for papers by Bertil Johansson Breakdown of academic impact, for papers by Letizia Foroni Breakdown of academic impact, for papers by H. R. Gralnick
Rankless by CCL
2026